Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

GRF Eagle Capital Growth Fund Inc

9,85

-0,10 (-1,01%)

14 Fév 2025 - Fermé

Retardé de 15 minutes

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

Eagle Capital Growth (AMEX:GRF)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025

Plus de graphiques de la Bourse Eagle Capital Growth

Eagle Capital Growth (AMEX:GRF)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025

Plus de graphiques de la Bourse Eagle Capital Growth

Actualités Eagle Capital Growth Fund Inc

Form 5 - Annual statement of changes in beneficial ownership of securities
Vendredi 14 Février 2025 ( il y a 2 jours) • Edgar (US Regulatory)

Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson’s Disease
Mardi 14 Janvier 2025 ( il y a 1 mois) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Jeudi 5 Décembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus
Mardi 19 Novembre 2024 ( il y a 3 mois) • GlobeNewswire Inc.

Eagle Capital Growth Fund Declares Year-End Distribution of $0.68 Per Share in Cash
Lundi 18 Novembre 2024 ( il y a 3 mois) • Business Wire

Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution
Mardi 29 Octobre 2024 ( il y a 4 mois) • GlobeNewswire Inc.

Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury
Mardi 22 Octobre 2024 ( il y a 4 mois) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Jeudi 3 Octobre 2024 ( il y a 4 mois) • Edgar (US Regulatory)

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat
Jeudi 3 Octobre 2024 ( il y a 4 mois) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 10 Septembre 2024 ( il y a 5 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 10 Septembre 2024 ( il y a 5 mois) • Edgar (US Regulatory)

GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339
Mercredi 31 Juillet 2024 ( il y a 7 mois) • GlobeNewswire Inc.

Plus d'articles sur Eagle Capital Growth Fund Inc

Societe Generale

JP Morgan Chase

Lvmh Moet Hennessy Louis...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales